Yi Fei Yang
Director/Board Member at RED PHASE INC.
Yi Fei Yang active positions
| Companies | Position | Start | End |
|---|---|---|---|
| RED PHASE INC. | Director/Board Member | 2021-03-21 | - |
| Independent Dir/Board Member | 2021-03-21 | - | |
| CHINA TOURISM AND CULTURE INVESTMENT GROUP CO.,LTD | Director/Board Member | 2022-12-19 | - |
| Independent Dir/Board Member | 2022-12-19 | - | |
Xiamen Zeesan Biotech Co., Ltd.
 Xiamen Zeesan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Xiamen Zeesan Biotech Co., Ltd. engages in the research and development, production, and sales of molecular diagnostic technology, molecular diagnostic reagents, and molecular diagnostic instruments. It specializes in molecular diagnostic reagent products and molecular diagnostic instrument products, provides the basis for disease screening and diagnosis, drug selection and efficacy monitoring of infectious diseases including respiratory disease and human papillomavirus infection, hematologic oncology, personalized medicine and genetic diseases. The company was founded on June 12, 2010 and is headquartered in Xiamen, China. | Director/Board Member | 2021-08-22 | - |
| Independent Dir/Board Member | 2021-08-22 | - |
Career history of Yi Fei Yang
Statistics
International
| China | 4 |
Operational
| Director/Board Member | 3 |
| Independent Dir/Board Member | 3 |
Sectoral
| Electronic Technology | 2 |
| Health Services | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| RED PHASE INC. | Electronic Technology |
| CHINA TOURISM AND CULTURE INVESTMENT GROUP CO.,LTD | Commercial Services |
| Private companies | 1 |
|---|---|
Xiamen Zeesan Biotech Co., Ltd.
Xiamen Zeesan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Xiamen Zeesan Biotech Co., Ltd. engages in the research and development, production, and sales of molecular diagnostic technology, molecular diagnostic reagents, and molecular diagnostic instruments. It specializes in molecular diagnostic reagent products and molecular diagnostic instrument products, provides the basis for disease screening and diagnosis, drug selection and efficacy monitoring of infectious diseases including respiratory disease and human papillomavirus infection, hematologic oncology, personalized medicine and genetic diseases. The company was founded on June 12, 2010 and is headquartered in Xiamen, China. | Health Services |
- Stock Market
- Insiders
- Yi Fei Yang
- Experience
